(186)Re-Liposomal Doxorubicin (Doxil): In Vitro Stability, Pharmacokinetics, Imaging and Biodistribution in a Head and Neck Squamous Cell Carcinoma Xenograft Model

Antzeko izenburuak

• Chemoradionuclide Therapy with (186)Re-Labeled Liposomal Doxorubicin: Toxicity, Dosimetry, and Therapeutic Response
  nork: Soundararajan, Anuradha, et al.
  Argitaratua: (2011)
• Chemoradionuclide Therapy with (186)Re-labeled Liposomal Doxorubicin in Combination with Radiofrequency Ablation for Effective Treatment of Head and Neck Cancer in a Nude Rat Tumor Xenograft Model
  nork: Soundararajan, Anuradha, et al.
  Argitaratua: (2011)
• Rhenium-186 liposomes as convection-enhanced nanoparticle brachytherapy for treatment of glioblastoma
  nork: Phillips, William T., et al.
  Argitaratua: (2012)
• Combination Radiofrequency Ablation and Intravenous Radiolabeled Liposomal Doxorubicin: Imaging and Quantification of Increased Drug Delivery to Tumors(1)
  nork: Head, Hayden W., et al.
  Argitaratua: (2010)
• Pharmaceutical and Biomedical Differences between Micellar Doxorubicin (NK911) and Liposomal Doxorubicin (Doxil)
  nork: Tsukioka, Yoshihisa, et al.
  Argitaratua: (2002)